Company intelligence / Profile preview

KBC

Iran

Ownership: Private
Employees: ~70
Development stage: Other

Overview

Kawsar Biotech Company develops and sells a variety of molecular biology diagnostic kits and provides genomics and genetic testing services. They are active in molecular diagnostics, identity testing, animal identification, and ancillary products for research and clinical use. Their products are used by researchers and medical laboratories across Iran and are actively working toward international certification for broader export.

Therapeutic areas: Rare DiseasesOther
Modalities: Diagnostic kitGenetic testing kit
Industry: Molecular Diagnostics

Partnerships

MRC Holland

Beyond the preview

Go deeper on KBC.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on KBC.

Explore the full profile